Senior insider sale
Chief Financial Officer at TERNS PHARMACEUTICALS, INC. — senior position signals high conviction
$52.1K
9.06K shares
What this filing means
VIGNOLA MARK J. plans to sell 9.06K shares of TERNS PHARMACEUTICALS, INC. valued at approximately $52.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/6/2025ACC: 0001950047-25-000156
Officer· Chief Financial Officer
Since Feb 2021
9.06K
Shares to sell
$52.1K
Approx. market value
9.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/1/2025
9.06KTotal acquired9.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2025 | Restricted Stock Units N/A | 9.06K | — |
| Total | 9.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.06K
Market value
$52.1K
1/6/2025
Total
Units
9.06K
Value
$52.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2025 | 9.06K | $52.1K | NASDAQ | Planned |
| Total | 9.06K | $52.1K | ||